[Dosaging of proton pumps inhibitors].
Lundin
Knut E A
KE
Kett
Kjell
K
D000863:Antacids / Q000008:administration & dosage*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D065731:Cytochrome P-450 CYP2C19; D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics; D011110:Polymorphism, Genetic; D054328:Proton Pump Inhibitors; D000254:Sodium-Potassium-Exchanging ATPase / Q000235:genetics
D000863:Antacids; D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D000254:Sodium-Potassium-Exchanging ATPase